Jazz Pharmaceuticals plc Contract Liability (Deferred Revenue)
Jazz Pharmaceuticals plc (JAZZ) had Contract Liability (Deferred Revenue) of $0 as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-02-28
- 2023-12-31: Contract with Customer, Liability, Current $0.00.
- 2023-09-30: Contract with Customer, Liability, Current $4.00K.
- 2023-06-30: Contract with Customer, Liability, Current $4.00K.
- 2023-03-31: Contract with Customer, Liability, Current $4.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2023-09-30 | $4.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $463.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $871.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.28M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $1.69M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $2.09M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.27M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.44M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $2.37M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $2.55M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.09M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $3.63M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $4.18M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $4.72M 10-K · filed 2021-02-23 |
| 2019-09-30 | $4.72M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $4.72M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $4.72M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $5.41M 10-K · filed 2020-02-25 |
| 2018-09-30 | $5.93M 10-Q · filed 2018-11-06 |
| 2018-01-01 | $7.50M 10-K · filed 2019-02-26 |
| 2017-12-31 | $8.62M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |